0
A Multidimensional Meta-Analysis of Psychotherapy for PTSD
Rebekah Bradley, Ph.D.; Jamelle Greene, M.A.; Eric Russ, B.A.; Lissa Dutra, M.A.; Drew Westen, Ph.D.
A Multidimensional Model of Obsessive-Compulsive Disorder
David Mataix-Cols, Ph.D.; Maria Conceição do Rosario-Campos, M.D.; James F. Leckman, M.D.
Gender Differences in Incidence and Age at Onset of Mania and Bipolar Disorder Over a 35-Year Period in Camberwell, England
Noel Kennedy, M.D., M.R.C.Psych.; Jane Boydell, M.D., M.R.C.Psych.; Sri Kalidindi, M.D., M.R.C.Psych.; Paul Fearon, M.D., M.R.C.Psych.; Peter B. Jones, M.D., Ph.D., M.R.C.Psych.; Jim van Os, M.D., Ph.D., M.R.C.Psych.; Robin M. Murray, M.D., D.Sc., F.R.Psych.
Male Body Image in Taiwan Versus the West: Yanggang Zhiqi Meets the Adonis Complex
Chi-Fu Jeffrey Yang; Peter Gray, Ph.D.; Harrison G. Pope, Jr., M.D., M.P.H.
Symptoms of Posttraumatic Stress Disorder and Borderline Personality Disorder in Veterans of Operation Desert Storm
Seth R. Axelrod, Ph.D.; C. Andrew Morgan, III, M.D.; Steven M. Southwick, M.D.
Increased PTSD Risk With Combat-Related Injury: A Matched Comparison Study of Injured and Uninjured Soldiers Experiencing the Same Combat Events
Danny Koren, Ph.D.; Doron Norman, M.D.; Ayala Cohen, Ph.D.; Jason Berman, M.A.; Ehud M. Klein, M.D.
Auditory Startle Response in Firefighters Before and After Trauma Exposure
Rachel M. Guthrie, Ph.D.; Richard A. Bryant, Ph.D.
Attention Bias to Threat in Maltreated Children: Implications for Vulnerability to Stress-Related Psychopathology
Daniel S. Pine, M.D.; Karin Mogg, Ph.D.; Brendan P. Bradley, Ph.D.; LeeAnne Montgomery, M.S.; Christopher S. Monk, Ph.D.; Erin McClure, Ph.D.; Amanda E. Guyer, Ph.D.; Monique Ernst, M.D., Ph.D.; Dennis S. Charney, M.D.; Joan Kaufman, Ph.D.
Suicide After Deliberate Self-Harm: A 4-Year Cohort Study
Jayne Cooper, R.M.N., Ph.D.; Navneet Kapur, M.D., M.R.C.Psych.; Roger Webb, M.Sc.; Martin Lawlor, M.B., M.R.C.Psych.; Else Guthrie, M.D., M.R.C.Psych.; Kevin Mackway-Jones, F.R.C.P., F.R.C.S., F.F.A.E.M.; Louis Appleby, M.D., F.R.C.Psych.
Impaired Decision Making in Suicide Attempters
Fabrice Jollant, M.S.; Frank Bellivier, M.D., Ph.D.; Marion Leboyer, M.D., Ph.D.; Bernard Astruc, M.D.; Stéphane Torres, M.D.; Régis Verdier, M.D.; Didier Castelnau, M.D.; Alain Malafosse, M.D., Ph.D.; Philippe Courtet, M.D., Ph.D.
Mental Health Service Delivery and Suicide Risk: The Role of Individual Patient and Facility Factors
Rani A. Desai, Ph.D., M.P.H.; David J. Dausey, Ph.D.; Robert A. Rosenheck, M.D.
Ethnic Differences in Patterns of Suicide Across the Life Cycle
Steven J. Garlow, M.D., Ph.D.; David Purselle, M.D.; Michael Heninger, M.D.
Relapse Prevention in Patients With Bipolar Disorder: Cognitive Therapy Outcome After 2 Years
Dominic H. Lam, Ph.D.; Peter Hayward, Ph.D.; Edward R. Watkins, Ph.D.; Kim Wright, B.A.; Pak Sham, Ph.D.
Lower Effectiveness of Divalproex Versus Valproic Acid in a Prospective, Quasi-Experimental Clinical Trial Involving 9,260 Psychiatric Admissions
Adel A. Wassef, M.D.; Diane E. Winkler, R.Ph.; Ann L. Roache, Pharm.D., B.C.P.P.; Vivian Boma Abobo, Pharm.D.; Lina M. Lopez, M.D.; John P. Averill, B.B.A.; Ayesha I. Mian, M.D.; John E. Overall, Ph.D.
Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence
Richard S. Schottenfeld, M.D.; Marek C. Chawarski, Ph.D.; Juliana R. Pakes, M.Ed.; Michael V. Pantalon, Ph.D.; Kathleen M. Carroll, Ph.D.; Thomas R. Kosten, M.D.
Prospective Evaluation of the Four DSM-IV Criteria for Alcohol Abuse in a Large Population
Marc A. Schuckit, M.D.; Tom L. Smith, Ph.D.; George P. Danko, Ph.D.; John Kramer, Ph.D.; Jessica Godinez, B.A.; Kathleen K. Bucholz, Ph.D.; John I. Nurnberger, Jr., M.D., Ph.D.; Victor Hesselbrock, Ph.D.
Additive Effects of HIV and Chronic Methamphetamine Use on Brain Metabolite Abnormalities
Linda Chang, M.D.; Thomas Ernst, Ph.D.; Oliver Speck, Ph.D.; Charles S. Grob, M.D.
Prevalence and Risk Factors for Homelessness and Utilization of Mental Health Services Among 10,340 Patients With Serious Mental Illness in a Large Public Mental Health System
David P. Folsom, M.D.; William Hawthorne, Ph.D.; Laurie Lindamer, Ph.D.; Todd Gilmer, Ph.D.; Anne Bailey, M.S.; Shahrokh Golshan, Ph.D.; Piedad Garcia, Ed.D.; Jürgen Unützer, M.D.; Richard Hough, Ph.D.; Dilip V. Jeste, M.D.
Hair Apparent: Rapunzel Syndrome
Ariel S. Frey, B.A., M.A.T.; Milissa McKee, M.D., M.P.H.; Robert A. King, M.D.; Andrés Martin, M.D., M.P.H.
Neuroactive Steroids and Suicidality in Posttraumatic Stress Disorder
Marian I. Butterfield, M.D., M.P.H.; Karen M. Stechuchak, M.S.; Kathryn M. Connor, M.D.; Jonathan R.T. Davidson, M.D.; Chungsheng Wang, M.D., Ph.D.; Courteney L. MacKuen; Anne M. Pearlstein; Christine E. Marx, M.D., M.A.
No Change in Serotonin Type 1A Receptor Binding in Patients With Posttraumatic Stress Disorder
Omer Bonne, M.D.; Earle Bain, M.D.; Alexander Neumeister, M.D.; Allison C. Nugent, Ph.D.; Meena Vythilingam, M.D.; Richard E. Carson, Ph.D.; David A. Luckenbaugh, M.A.; William Eckelman, Ph.D.; Peter Herscovitch, M.D.; Wayne C. Drevets, M.D.; Dennis S. Charney, M.D.
Improved P50 Auditory Gating With Ondansetron in Medicated Schizophrenia Patients
Lawrence E. Adler, M.D.; Ellen M. Cawthra, R.N.; Kara A. Donovan, M.P.H.; Josette G. Harris, Ph.D.; Herbert T. Nagamoto, M.D.; Ann Olincy, M.D.; Merilyne C. Waldo, Ph.D.
Double-Blind, Placebo-Controlled, Multicenter Trial of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Outpatients With Schizophrenia
J. Alexander Bodkin, M.D.; Samuel G. Siris, M.D.; Paul C. Bermanzohn, M.D.; John Hennen, Ph.D.; Jonathan O. Cole, M.D.
fMRI of Response to Nicotine During a Smooth Pursuit Eye Movement Task in Schizophrenia
Jason R. Tregellas, Ph.D.; Jody L. Tanabe, M.D.; Laura F. Martin, M.D.; Robert Freedman, M.D.
Effects of Ketamine on Anterior Cingulate Glutamate Metabolism in Healthy Humans: A 4-T Proton MRS Study
Laura M. Rowland, Ph.D.; Juan R. Bustillo, M.D.; Paul G. Mullins, Ph.D.; Rex E. Jung, Ph.D.; Rhoshel Lenroot, M.D.; Elma Landgraf, B.S.; Ranee Barrow, B.S.; Ronald Yeo, Ph.D.; John Lauriello, M.D.; William M. Brooks, Ph.D.
Possible Neuroleptic Malignant Syndrome With Aripiprazole and Fluoxetine
HARPREET S. DUGGAL, M.D., D.P.M.; JOSEPH KITHAS, M.D.
Risperidone-Induced Morning Pseudoneutropenia
DAVID ESPOSITO, M.D.; EMMANUELLE CORRUBLE, M.D., Ph.D.; PATRICK HARDY, M.D., Ph.D.; GUY CHOUINARD, M.D., M.Sc.
Dr. Cohen and Colleagues Reply
HAGIT COHEN, Ph.D.; MICHAEL A. MATAR, M.D.; ZEEV KAPLAN, M.D.; NIMROD GRISARU, M.D.
Comorbidity and Disability in Outpatients With Schizophrenia
MAURO V. MENDLOWICZ, M.D.; RAPHAEL J. BRAGA, M.D.; ROGÉRIO P. MARROCOS, M.D.; IVAN FIGUEIRA, M.D.
Dr. Pallanti and Colleague Reply
STEFANO PALLANTI, M.D.; LEONARDO QUERCIOLI, M.D.; ERIC HOLLANDER, M.D.
Cannabis Use and Schizophrenia
MARIE-ODILE KREBS, M.D., Ph.D.; CELINE GOLDBERGER, M.D., M.Sc.; ALAIN DERVAUX, M.D.
Dr. Hakkarainen and Colleagues Reply
REETA HAKKARAINEN, M.B.; TIMO PARTONEN, M.D.; JARI HAUKKA, Ph.D.; JARMO VIRTAMO, M.D.; DEMETRIUS ALBANES, M.D.; JOUKO LÖNNQVIST, M.D., Ph.D.
Dr. Veen and Colleagues Reply
NATALIE D. VEEN, M.D.; JEAN-PAUL SELTEN, M.D., Ph.D.; RENÉ S. KAHN, M.D., Ph.D.
Dr. Oquendo and Colleagues Reply
MARIA A. OQUENDO, M.D.; ANDRES BARRERA, M.D.; STEVEN P. ELLIS, Ph.D.; SHUHUA LI, M.D.; AINSLEY K. BURKE, Ph.D.; MICHAEL GRUNEBAUM, M.D.; JEAN ENDICOTT, Ph.D.; J. JOHN MANN, M.D.
Instability of Symptoms in Recurrent Major Depression
MICHAEL H. ALLEN, M.D.; CHERYL A. CHESSICK, M.D.
Tardive Dyskinesia and Second-Generation Antipsychotics
SUDEEP SARAF, M.D.; PRABHA S. CHANDRA, M.D.
Dr. Correll and Colleagues Reply
CHRISTOPH U. CORRELL, M.D.; JOHN M. KANE, M.D.; STEFAN LEUCHT, M.D.